Applying Patient-Specific Induced Pluripotent Stem Cells to Create a Model of Hypertrophic Cardiomyopathy

被引：13
|
作者：
Dementyeva, E. V. [1 ,2 ,3 ]
Medvedev, S. P. [1 ,2 ,3 ,4 ]
Kovalenko, V. R. [1 ,2 ,3 ,4 ]
Vyatkin, Yu. V. [4 ,5 ]
Kretov, E. I. [2 ]
Slotvitsky, M. M. [6 ]
Shtokalo, D. N. [5 ,7 ]
Pokushalov, E. A. [2 ]
Zakian, S. M. [1 ,2 ,3 ,4 ]
机构：
[1] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Fed Res Ctr, Novosibirsk 630090, Russia
[2] Minist Hlth Russian Federat, Meshalkin Natl Med Res Ctr, Novosibirsk 630055, Russia
[3] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk 630090, Russia
[4] Novosibirsk State Univ, Novosibirsk 630090, Russia
[5] Novel Software Syst Ltd, Novosibirsk 630090, Russia
[6] Moscow Inst Phys & Technol, Dolgoprudnyi 141701, Moscow Region, Russia
[7] AP Ershov Inst Informat Syst, Novosibirsk 630090, Russia
来源：
BIOCHEMISTRY-MOSCOW | 2019年 / 84卷 / 03期
基金：
俄罗斯科学基金会;
关键词：
induced pluripotent stem cells; human disease models; hypertrophic cardiomyopathy; cardiomyocytes; GENETICS;
D O I：
10.1134/S0006297919030118
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Generation of patient-specific induced pluripotent stem cells (iPSCs) and their subsequent differentiation into cardiomyocytes opened new opportunities for studying pathogenesis of inherited cardiovascular diseases. One of these diseases is hypertrophic cardiomyopathy (HCM) for which no efficient therapy methods have been developed so far. In this study, the approach based on patient-specific iPSCs was applied to create a model of the disease. Genetic analysis of a hypertrophic cardiomyopathy patient revealed R326Q mutation in the MYBPC3 gene. iPSCs of the patient were generated and characterized. The cells were differentiated into cardiomyocytes together with the control iPSCs from a healthy donor. The patient's iPSC-derived cardiomyocytes exhibited early HCM features, such as abnormal calcium handling and increased intracellular calcium concentration. Therefore, cardiomyocytes obtained by directed differentiation of iPSCs from the HCM patient can be used as a model system to study HCM pathogenesis.
引用
收藏
页码：291 / 298
页数：8
相关论文
共 50 条
  • [31] Patient-specific KITD816V induced pluripotent Stem Cells
    de Toledo, Szymanski M. A.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 159 - 160
  • [32] Modelling Brugada syndrome using patient-specific induced pluripotent stem cells
    Stauske, M.
    Wagner, S.
    Li, W.
    Maier, L.
    Hasenfuss, G.
    Guan, K.
    EUROPEAN HEART JOURNAL, 2014, 35 : 380 - 380
  • [33] Patient-specific induced pluripotent stem cells (iPSCs) to model disease pathology in metachromatic leukodystrophy.
    Meneghini, V.
    Frati, G.
    Cavazzin, C.
    Lombardo, A.
    Naldini, L.
    Gritti, A.
    HUMAN GENE THERAPY, 2012, 23 (10) : A89 - A89
  • [34] Translational potential of patient-specific human pluripotent stem cells
    Agarwal, Suneet
    FASEB JOURNAL, 2010, 24
  • [35] Induced pluripotent stem cells as a platform to understand patient-specific responses to opioids and anaesthetics
    Obal, Detlef
    Wu, Joseph C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (20) : 4581 - 4594
  • [36] Patient-specific Induced Pluripotent Stem Cells For Modeling Hypoplastic Left Heart Syndrome
    Kobayashi, Junko
    Yoshida, Masashi
    Tarui, Suguru
    Hirata, Masataka
    Takahashi, Ken
    Kasahara, Shingo
    Naruse, Keiji
    Ito, Hiroshi
    Sano, Shunji
    Oh, Hidemasa
    CIRCULATION, 2012, 126 (21)
  • [37] GENERATION OF ARPKD KIDNEY ORGANOIDS USING PATIENT-SPECIFIC INDUCED PLURIPOTENT STEM CELLS
    Fluhr, Theresa Leonie
    Tabatabaeifar, Mansoureh
    Schaefer, Franz
    PEDIATRIC NEPHROLOGY, 2022, 37 (11) : 2825 - 2825
  • [38] Engineering Vascular Tissue with Biomimetic Scaffolds and Patient-specific Induced Pluripotent Stem Cells
    Hu, J.
    Wang, Y.
    Jiao, J.
    Forde, K.
    Yang, B.
    Chen, Y. E.
    Ma, P. X.
    TISSUE ENGINEERING PART A, 2015, 21 : S28 - S29
  • [39] Modeling congenital cataract in vitro using patient-specific induced pluripotent stem cells
    Lyu, Danni
    Zhang, Lifang
    Qin, Zhenwei
    Ni, Shuang
    Li, Jiayong
    Lu, Bing
    Hao, Shengjie
    Tang, Qiaomei
    Yin, Houfa
    Chen, Zhijian
    Yan, Yong-Bin
    Ji, Junfeng
    He, Jiliang
    Nagy, Andras
    Fu, Qiuli
    Yao, Ke
    NPJ REGENERATIVE MEDICINE, 2021, 6 (01)
  • [40] Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery
    Tang, Shibing
    Xie, Min
    Cao, Nan
    Ding, Sheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (01) : 2 - 15
12345